Qatar | Imports and Exports | World | Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
Where does Qatar export Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc?
Top export destinations of "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from Qatar in 2023:
Exports structure of 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc - from Qatar in 2023 represented by the following main commodity groups:
The value of imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to Qatar totalled $ 192 million in 2023. Sales of commodity group 3002 to Qatar decreased by 37% in value terms compared to 2022. imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" decreased by $ 117 million (the value of imports of commodity group 3002 to Qatar was equal to $309 million in 2022)
Imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" accounted for 0.613% of total import flow to Qatar (in 2023, total imports to Qatar amounted to $ 31 billion). The share of commodity group 3002 in total imports to Qatar decreased by 0.312 p.p. compared to 2022 (it was 0.925% in 2022 and cumulative imports to Qatar were equal to $ 33 billion).
Imports of commodity group 3002 reached 20% of total imports of group "" to Qatar in 2023 (imports of commodity group to Qatar totalled $928 million in 2023). The share of purchases of commodity group 3002 in imports of commodity group to Qatar went down by 11 p.p. compared to 2022 (it was 31% in 2022, and imports of commodity group to Qatar accounted for $973 million).
Where does Qatar import Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc from?
Top trading partners (import of "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc") of Qatar in 2023:
- USA with a share of 26% (50 million US$)
- Switzerland with a share of 24% (46 million US$)
- Germany with a share of 16.6% (32 million US$)
- Italy with a share of 6.53% (12.6 million US$)
- Ireland with a share of 6.49% (12.5 million US$)
- France with a share of 6.15% (11.8 million US$)
- Belgium with a share of 3.42% (6.59 million US$)
- Singapore with a share of 1.94% (3.75 million US$)
- United Kingdom with a share of 1.54% (2.97 million US$)
- Denmark with a share of 1.48% (2.85 million US$)
Imports structure of 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc - to Qatar in 2023 represented by the following main commodity groups:
- 1.22% (2.37 million US$): 300290 - Human blood; animal blood prepared for therapeutic/prophylactic/diagnostic uses; toxins, cultures of micro-organisms (excl. yeasts) & sim. products
